DaVita Inc. (DVA)
NYSE: DVA · Real-Time Price · USD
183.69
-0.08 (-0.04%)
At close: Aug 10, 2026, 4:00 PM EDT
183.50
-0.19 (-0.10%)
After-hours: Aug 10, 2026, 7:58 PM EDT
DaVita Employees
DaVita had 78,000 employees as of December 31, 2025. The number of employees increased by 2,000 or 2.63% compared to the previous year.
Employees
78,000
Change (1Y)
2,000
Growth (1Y)
2.63%
Revenue / Employee
$179,611
Profits / Employee
$10,865
Market Cap
11.71B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 78,000 | 2,000 | 2.63% |
| Dec 31, 2024 | 76,000 | 6,000 | 8.57% |
| Dec 31, 2023 | 70,000 | 0 | - |
| Dec 31, 2022 | 70,000 | 1,000 | 1.45% |
| Dec 31, 2021 | 69,000 | 2,000 | 2.99% |
| Dec 31, 2020 | 67,000 | 2,000 | 3.08% |
| Dec 31, 2019 | 65,000 | -12,700 | -16.34% |
| Dec 31, 2018 | 77,700 | 3,200 | 4.30% |
| Dec 31, 2017 | 74,500 | 4,200 | 5.97% |
| Dec 31, 2016 | 70,300 | 9,900 | 16.39% |
| Dec 31, 2015 | 60,400 | 2,500 | 4.32% |
| Dec 31, 2014 | 57,900 | 500 | 0.87% |
| Dec 31, 2013 | 57,400 | 4,000 | 7.49% |
| Dec 31, 2012 | 53,400 | 12,400 | 30.24% |
| Dec 31, 2011 | 41,000 | 4,500 | 12.33% |
| Dec 31, 2010 | 36,500 | 2,500 | 7.35% |
| Dec 31, 2009 | 34,000 | 1,500 | 4.62% |
| Dec 31, 2008 | 32,500 | 1,500 | 4.84% |
| Dec 31, 2007 | 31,000 | 2,100 | 7.27% |
| Dec 31, 2006 | 28,900 | 900 | 3.21% |
| Dec 31, 2005 | 28,000 | 12,700 | 83.01% |
| Dec 31, 2004 | 15,300 | 1,500 | 10.87% |
| Dec 31, 2003 | 13,800 | 800 | 6.15% |
| Dec 31, 2002 | 13,000 | 300 | 2.36% |
| Dec 31, 2001 | 12,700 | 500 | 4.10% |
| Dec 31, 2000 | 12,200 | -100 | -0.81% |
| Dec 31, 1999 | 12,300 | 0 | - |
| Dec 31, 1998 | 12,300 | 3,470 | 39.30% |
| Dec 31, 1997 | 8,830 | 5,705 | 182.56% |
| Dec 31, 1996 | 3,125 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius Medical Care AG | 109,698 |
| Universal Health Services | 101,500 |
| Tenet Healthcare | 99,000 |
| PACS Group | 47,455 |
| The Ensign Group | 46,000 |
| Encompass Health | 42,300 |
| Chemed | 15,811 |
| National HealthCare | 15,278 |
DVA News
- 3 days ago - DaVita price target lowered to $215 from $250 at Truist - TheFly
- 3 days ago - DaVita upgraded to Buy from Hold at TD Cowen - TheFly
- 5 days ago - DaVita price target raised to $265 from $220 at Deutsche Bank - TheFly
- 5 days ago - DaVita price target raised to $170 from $145 at BofA - TheFly
- 5 days ago - DaVita price target raised to $224 from $218 at Barclays - TheFly
- 6 days ago - DaVita flags lower revenue per treatment, reaffirms annual forecast - Reuters
- 6 days ago - DaVita Earnings Call Transcript: Q2 2026 - Transcripts
- 6 days ago - DaVita Earnings release: Q2 2026 - Filings